Therefore, the present researches aimed to investigate the mechanisms for SREBP1c‐dependent inhibition of HSC activation and liver fibrosis in vivo and in vitro and mainly focused on the influences of SREBP1c on the protein levels of the important molecules and signalling pathways which were associated with HSC activation and liver fibrosis. The gene discussed is SREBF1; the disease is Hepatic fibrosis.